Wellcome Trust Sanger Institute Promotes Mike Stratton to Director

The institute's deputy director since 2007, Stratton is a team leader of Sanger's Cancer Genome Project, and a leader of the International Cancer Gene Consortium. He succeeds Allan Bradley, who in March stepped down after 10 years at the institute's helm.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories